Horizon Investments’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
DAM
F
Horizon Investments's NVO Position: Q1 2026 in Review
Horizon Investments increased its Novo Nordisk (NVO) stake by 470% in Q1 2026, buying an estimated $37K and bringing the position to 946 shares worth $34.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1148.
Horizon Investments first reported a position in NVO in Q4 2016 and has held it in 18 quarters since. The position peaked at $3.34M in Q3 2019. 1,276 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- Horizon Investments held 946 shares of Novo Nordisk worth $34.8K as of Q1 2026.
- Horizon Investments bought 780 Novo Nordisk shares in Q1 2026, an estimated $37K.
- Novo Nordisk made up ﹤0.01% of Horizon Investments's portfolio in Q1 2026, its #1148 holding.
- Horizon Investments first reported a position in Novo Nordisk in Q4 2016 and has held it in 18 quarters since.
- Horizon Investments's Novo Nordisk position peaked at $3.34M in Q3 2019.
- 1,276 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on Horizon Investments's 13F filing for Q1 2026, filed 15 May 2026.